Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network
在真实世界轴性脊柱关节炎患者队列中，与肿瘤坏死因子抑制剂相比，Janus激酶抑制剂和白细胞介素-17抑制剂的药物生存期较短——来自RHADAR网络的回顾性分析
期刊:Rheumatology International
影响因子:2.9
doi:10.1007/s00296-024-05671-9
Strunz, Patrick-Pascal; Englbrecht, Matthias; Risser, Linus Maximilian; Witte, Torsten; Froehlich, Matthias; Schmalzing, Marc; Gernert, Michael; Schmieder, Astrid; Bartz-Bazzanella, Peter; von der Decken, Cay; Karberg, Kirsten; Gauler, Georg; Wurth, Patrick; Späthling-Mestekemper, Susanna; Kuhn, Christoph; Vorbrüggen, Wolfgang; Heck, Johannes; Welcker, Martin; Kleinert, Stefan
